Micro Labs Limited, a fully integrated pharmaceutical company with headquarters in Bengaluru, India, has acquired Swiss Pharma Nigeria Limited (Swipha).
Avyakta Law acted as the legal advisor of Micro Labs. The transaction team was led by Shameek Chaudhuri (Managing Partner), with Kshitij Goel (Associate).
Micro Labs, with a robust network of 14 formulation plants, including an injectable unit and bulk drug facility, operates international offices in key regions such as the United States, the United Kingdom, Germany, Australia, and Nigeria, as well as representative offices in emerging markets. In Nigeria, the company has operated through its subsidiary Micro Nova Pharmaceutical Ind. Limited for over a decade.
Swipha, established in 1976, is a leading pharmaceutical company in Nigeria, dedicated to delivering high-quality, affordable medicines to improve healthcare outcomes in Nigeria and across Africa.
This acquisition marks a significant milestone in Micro Labs' strategic expansion in the Nigerian and broader African market.
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.